Effects of a Novel Gel Formulation of Dog Appeasing Pheromone (DAP) on Behavioral and Physiological Stress Responses in Dogs Undergoing Clinical Examination.
Ivana PuglisiMarisa MasucciAlessandro CozziEva TeruelMichele NavarraSanta CirmiMaria Grazia PennisiCarlo SiracusaPublished in: Animals : an open access journal from MDPI (2022)
The veterinary visit is necessary for safeguarding the health of dogs, but it can be stressful and threaten both the welfare of the patient and the accuracy of the examination. This randomized, triple-blind, placebo-controlled, crossover study aims at evaluating how dog appeasing pheromone (DAP) in a novel gel formulation influences the behavioral and physiological stress responses of 28 dogs undergoing a standardized clinical examination, while staying in the waiting room (WR) and visited in the examination room (ER). Behavioral responses were studied through behavioral categories and subjective scales (WR and ER). Autonomic response considered heart rate (WR and ER), blood pressure (WR and ER), respiratory rate (ER), and rectal temperature (ER). Neuroendocrine response considered salivary cortisol (WR and ER). In the waiting room, the use of DAP was associated with a significant reduction of lip licking ( p = 0.0189), an increase in panting ( p = 0.0276), and a reduction close to significance ( p = 0.0584) of low body postures. No significant differences were observed within the physiological responses. In the examination room, neither behavioral nor physiological differences were found.
Keyphrases
- healthcare
- heart rate
- endoplasmic reticulum
- estrogen receptor
- blood pressure
- breast cancer cells
- heart rate variability
- placebo controlled
- drug delivery
- clinical trial
- mental health
- public health
- depressive symptoms
- open label
- study protocol
- metabolic syndrome
- randomized controlled trial
- adipose tissue
- phase ii
- radiation therapy
- case report
- hyaluronic acid
- skeletal muscle
- climate change
- insulin resistance
- glycemic control